The Recovery Project Review

What The Recovery Project charges

The Recovery Project does not publish a price today.

The Recovery Project also sells 12 compounds this site boards without publishing a price for them: BPC-157 (board ranks no provider), CJC-1295 (board ranks no provider), Epitalon (board ranks no provider), GHK-Cu, Ipamorelin (board ranks no provider), KPV (board ranks no provider), MOTS-C (board ranks no provider), NAD+, Semax (board ranks no provider), Sermorelin, TB-500 (board ranks no provider) and Tesamorelin.

One of the widest catalogs here

Twelve tracked compounds are named: BPC-157, CJC-1295, epitalon, GHK-Cu, ipamorelin, KPV, MOTS-c, NAD+, semax, sermorelin, TB-500 and tesamorelin.

KPV, MOTS-c and semax are the rare entries. Most sellers on this roster never name them, so a reader hunting an uncommon compound has a genuine reason to be here.

Breadth is the argument this site makes. Whatever else is thin, the menu is real and it is longer than almost anything else in this comparison.

The list is navigation, not twelve descriptions

The same twelve names appear identically on every page read. They function as a catalog in the navigation rather than as twelve separately described products.

So the site is wide and not deep on any single compound. A reader looking for dosing detail, protocol length, or a case for one peptide over another will not find it laid out compound by compound.

No figure anywhere on the site

Not one page read carries a cost. There is no rate, no starting figure, and no billing period attached to anything on the menu.

The site is followable and reasonably deep, which makes the absence look like a decision rather than an oversight. Cost is simply not something this seller publishes.

A reader comparing on price has nothing to work with until they call. That is a real barrier when a competing seller prints a monthly rate on the page.

Nothing to look up

No corporate entity appears anywhere on the pages read. The brand is the only name published, so there is no company record for a reader to check.

No page names a dispensing pharmacy, and none lists the states served. Lab work is not described as covered by anything the site charges.

That combination leaves a reader with a compound list and very little else to verify. Here, the menu is the disclosure.

How we verified this

• Recorded the twelve tracked compounds named on the site, and noted that the same list appears identically on every page read.
• Opened every page read looking for a cost, and recorded that none carries a figure of any kind.
• Searched the pages read for a corporate entity and found the brand named alone.
• Checked for a named dispensing pharmacy, a list of states served, and any statement that lab work is covered.
• Fired a nonsense address at the host in the same run, which returned a small hard error page, and screened the brand in the federal warning-letter record with a known-positive and a nonsense control.